Catalyst Wire Dossier Catalyst Wire Dossier

VANRAFIA

Atrasentan · Novartis Pharmaceuticals Corporation
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VANRAFIA, covering 2025-04-02 to 2025-10-20. Get the full timeline:

Most recent: FDA Approved: VANRAFIA — Supplemental Application (Novartis Pharmaceuticals Corporation)

See pricing